EPHX2 and acute kidney injury: The association between increased sEH activity and AKI identified in this study, coupled with a growing body of research supporting a protective effect of sEH inhibition in rodent models [32, 35, 36, 58, 59], suggests that pharmacologic inhibition of sEH should be tested in clinical trials to assess its effect on AKI in patients undergoing cardiac surgery.